Huawei Cloud Pangu Drug Molecule Model hikes the drug discovery

Huawei and the drug-related topic might sound different but it’s quite effective. In the ongoing Connect 2022 event, Huawei uttered about how the Cloud Pangu Drug Molecule model elevated pharmaceutical R&D and new drug discovery.

Let’s explore this information from the beginning. We all know that the Chinese tech giant is working in every field. Whether it’s the technology sector or the medical institutes, Huawei is providing solutions in every sector, to date.

Recently, the company came in touch with some new pharmaceutical matters. Further, it realized that over 1 billion USD and approx 10 years requirement can imply a new drug in the market.

Meanwhile, at the time of developing antibiotics, the operators discovered that some bacteria are constantly emerging even before the newly-developed antibiotics could finish clinical tests. As a result, everyone started searching for a solution.

In such a scenario, Professor Liu Bing of the First Affiliated Hospital of the Medical School at Xi’an Jiatong University tried some methods. He and his team used the Huawei Cloud Pangu Molecule model and generated a new all-around antimicrobial drug within a month. Also, the R&D cost got a reduction by 70 percent.

From four years to just one month!

New drug development includes several procedures. It’s no less than a challenge as one has to do the screening of hundreds of millions of molecules. So far, the operators and experts used to conduct the screening in the lab which was quite costly, as well as slow at the same time.

At such a challenging phase, Huawei Cloud Pangu Molecule technology has proved a boon for the operators. The company has manufactured the technique by using the data of 1.7 billion drug-life molecules. Furthermore, the technology is capable of defining the drug compounds and their properties.

Apart from these merits, the molecular model can also optimize the structure of the lead components. Thus, experts can minimize the potential side effect of new drugs on human cells. Eventually, a new advantage that possibly turns four years of hard work and process into a month is on the market. And can make new drug discovery quite easier and more efficient.

(Source)